Bill Ackman Valeant

Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) have plunged roughly 90 percent over the past year and the company's mounting debt load is having investors think the company's only path towards long-term survival is selling off core assets. Billionaire hedge fund manager and...